New Immunosuppressive Agents for the Treatment of Sjögren’s Syndrome

Carsons, Steven E.

doi:10.1007/978-0-85729-947-5_39

Cited by 1 publication

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of SS patients were women, and women over the age of 40 when they were first diagnosed. Women are more likely to get the disease than men 2–4 22. Risk of herpes zoster increases with age, and women have a greater risk of developing herpes zoster than men 23.…”

Section: Methodsmentioning

confidence: 99%

Association between a History of herpes zoster and the risk of Sjögren’s syndrome: a nationwide, population-based, case–control study

Huang

Lin

et al. 2022

BMJ Open

View full text Add to dashboard Cite

ObjectiveViral infection is an exogenous factor for Sjögren’s syndrome (SS). The relationship between herpes zoster infection and the ensuring risk of SS has remained unclear. This study investigated the association between a history of herpes zoster infection and the risk of SS through a nationwide population-based case–control study.DesignRetrospective case–control study.SettingGeneral population of Taiwan.Data source2003–2013 National Health Insurance Research Database of Taiwan.ParticipantsWe identified all patients with newly diagnosed SS between 1 January 2007 and 31 December 2012 without a history of rheumatoid arthritis or systemic lupus erythematosus as the SS group.ControlsWe randomly selected patients without SS between 1 January 2003 and 31 December 2012 and matched 1:5 with controls based on index year, age and sex.Main outcome measureConditional logistic regression analysis to examine the association between a history of herpes zoster and the risk of SS.ResultsThe study included 5751 patients with SS and 28 755 matched controls. The risk of SS was significantly associated with a history of herpes zoster (model A (adjusted for Charlson Comorbidity Index (CCI) (excluding connective tissue disease, CTD)): OR 1.89; 95% CI 1.71 to 2.08; model B (adjusted for comorbidities used to calculate CCI (excluding CTD)): OR 1.90; 95% CI 1.72 to 2.10), in particular if the interval from the last visit for herpes zoster infection to the index date was <3 months (model A: OR 3.09; 95% CI 2.20 to 4.34; model B: OR 3.13; 95% CI 2.20 to 4.45). Such associations remained robust using various definitions of herpes zoster.ConclusionThis nationwide, population-based, case–control study revealed a significant association between a history of herpes zoster and the risk of SS.

show abstract

Section: Methodsmentioning

confidence: 99%